drugset / Trial / NCT03061136

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

NCT03061136

RandomizedCrossoverTriple-blindTreatment

Summary

Cognitive deficits are some of the most prominent and disabling symptoms of schizophrenia. Evidence suggests that schizophrenia involves alterations to the functioning of a neural system under the control of a brain chemical called GABA. The present project will compare the effects of low-dose clonazepam (at a sub-sedating dose) to placebo, for effects on GABA- modulated brain activity measured by EEG, and associated cognitive processes in people who have schizophrenia.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule 0.1 mg Oral
Subject Clonazepam Small molecule 0.2 mg Oral
Subject Clonazepam Small molecule 0.3 mg Oral